Boston Scientific's Watchman Gets Positive Medicare Coverage Policy
This article was originally published in Clinica
Executive Summary
The Center for Medicare and Medicaid Services has put into place a national coverage policy for Boston Scientific's Watchman left atrial appendage closure device for stroke. In doing so, the agency removed some previously proposed coverage conditions that would have made use of the technology in the Medicare population a steep challenge.